- Home
- ANGI vs INVA Comparison
ANGI vs INVA Comparison
Compare ANGI & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGI
- INVA
- Stock Information
- Founded
- ANGI 2017
- INVA 1996
- Country
- ANGI United States
- INVA United States
- Employees
- ANGI N/A
- INVA N/A
- Industry
- ANGI Advertising
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- ANGI Consumer Discretionary
- INVA Health Care
- Exchange
- ANGI Nasdaq
- INVA Nasdaq
- Market Cap
- ANGI 1.3B
- INVA 1.2B
- IPO Year
- ANGI 2017
- INVA 2004
- Fundamental
- Price
- ANGI $1.70
- INVA $17.68
- Analyst Decision
- ANGI Buy
- INVA Buy
- Analyst Count
- ANGI 9
- INVA 1
- Target Price
- ANGI $3.09
- INVA N/A
- AVG Volume (30 Days)
- ANGI 974.3K
- INVA 625.6K
- Earning Date
- ANGI 02-11-2025
- INVA 02-27-2025
- Dividend Yield
- ANGI N/A
- INVA N/A
- EPS Growth
- ANGI N/A
- INVA 46.55
- EPS
- ANGI 0.06
- INVA 0.99
- Revenue
- ANGI $1,217,676,000.00
- INVA $352,745,000.00
- Revenue This Year
- ANGI N/A
- INVA $16.20
- Revenue Next Year
- ANGI N/A
- INVA N/A
- P/E Ratio
- ANGI $26.91
- INVA $17.85
- Revenue Growth
- ANGI N/A
- INVA 21.46
- 52 Week Low
- ANGI $1.49
- INVA $14.33
- 52 Week High
- ANGI $3.10
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- ANGI 47.97
- INVA 41.38
- Support Level
- ANGI $1.49
- INVA $17.01
- Resistance Level
- ANGI $1.71
- INVA $17.53
- Average True Range (ATR)
- ANGI 0.08
- INVA 0.26
- MACD
- ANGI 0.02
- INVA 0.05
- Stochastic Oscillator
- ANGI 91.54
- INVA 69.07
About ANGI Angi Inc.
Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. The Company has three operating segments namely, Ads and Leads that generate maximum revenue, Services, and International (Europe and Canada). The company operates under multiple brands that including Angi, HomeAdvisor, and Handy. The majority of the revenue is earned from the United States.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.